Loading..
  • SynAct Pharma logoSVE
  • SynAct Pharma logoENG
  • About us
    • The Company in brief
    • Vision
    • History
    • Organisation
    • New Partnerships
  • Our Science
    • Resolving Inflammation
    • Selective Melanocortin Stimulation
    • Scientific Advisory Board
  • Pipeline
    • Pipeline Overview
    • The AP1189 Development Program
    • Rheumatoid Arthritis
    • Membranous Nephropathy
    • Virus Induced Respiratory Insufficiency
    • Ongoing clinical studies
  • Investors
    • Listing Nasdaq 2022
    • Rights Issue 2022
    • Word from the CEO
    • Financial Reports
    • Investment highlights
    • Presentations
    • The Share
      • Share price development
      • Ownership Structure
      • Insiders
      • Share Capital Development
    • Analyst Coverage
    • Calendar
    • Press Releases
    • Prospectuses
  • Governance
    • General Meetings
    • Corporate Governance Report
    • Nomination Committee
      • Nomination Committee 2023
    • Board of Directors
      • Remuneration Committee
      • Audit Committee
    • Management
    • Auditor
    • Articles of Association
    • Code of Conduct
  • Media
    • Press Releases
    • Synact in Media
    • Image Bank
    • Subscribe
  • Contact

Calendar

All years
  • Upcoming events
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • All years
  • 31
    Aug
    August 31, 2016
    Delårsrapport Q2, 2016
    Add to calendar
  • 04
    Nov
    November 4, 2016
    Delårsrapport Q3, 2016
    Add to calendar
  • 27
    Jan
    January 27, 2017
    SynAct Pharma presenterar i Köpenhamn
    Add to calendar
  • 31
    Jan
    January 31, 2017
    SynAct Pharma presenterar på Aktiedagen i Lund
    Add to calendar
  • 09
    Feb
    February 9, 2017
    Bokslutskommuniké för 2016
    Add to calendar
  • 08
    Mar
    March 8, 2017
    SynAct Pharma presenterar på Life Science-dagen 2017
    Add to calendar
  • 10
    Mar
    March 10, 2017
    SynAct Pharma presenterar i Stockholm
    Add to calendar
  • 14
    Mar
    March 14, 2017
    SynAct Pharma presenterar på Aktiedagen i Jönköping
    Add to calendar
  • 11
    May
    May 11, 2017
    Årsstämma 2017
    Add to calendar
  • 11
    May
    May 11, 2017
    Delårsrapport Q1 2017
    Add to calendar
  • 31
    Aug
    August 31, 2017
    Halvårsrapport 2017
    Add to calendar
  • 03
    Nov
    November 3, 2017
    Delårsrapport Q3 2017
    Add to calendar
  • 06
    Nov
    November 6 - November 7, 2017
    BIO-Europe Berlin
    Add to calendar
  • 16
    Nov
    November 16, 2017
    Sedermeradagen Stockholm
    Add to calendar
  • 08
    Jan
    8 - 11 januari, 2018
    J.P. Morgan Healthcare Conference 2018
    Add to calendar
  • 13
    Feb
    February 13, 2018
    Bokslutskommuniké 2017
    Add to calendar
  • 07
    Mar
    March 7, 2018
    Life Science-dagen Göteborg
    Add to calendar
  • 13
    Mar
    March 13, 2018
    Sedermeradagen Köpenhamn
    Add to calendar
  • 10
    Apr
    April 10, 2018
    Extra bolagsstämma 2018
    Add to calendar
  • 18
    Apr
    April 18, 2018
    BioStock Live i Lund
    Add to calendar
  • 19
    Apr
    April 19, 2018
    Delårsrapport Q1 2018
    Add to calendar
  • 23
    Apr
    April 23, 2018
    Aktiespararna i Stockholm.
    Add to calendar
  • 03
    May
    May 3, 2018
    Aktiespararna Operaterrassen Stockholm
    Add to calendar
  • 15
    May
    May 15, 2018
    Årsstämma 2018
    Add to calendar
  • 15
    May
    May 15, 2018
    Sedermeradagen Malmö
    Add to calendar
  • 30
    Aug
    August 30, 2018
    Halvårsrapport 2018
    Add to calendar
  • 05
    Nov
    November 5 - November 6, 2018
    Bio Europe, Copenhagen
    Add to calendar
  • 07
    Nov
    7 november, 2018
    SedermeraDagen, Stockholm
    Add to calendar
  • 16
    Nov
    November 16, 2018
    Delårsrapport Q3 2018
    Add to calendar
  • 11
    Feb
    February 11, 2019
    Bokslutskommuniké 2018
    Add to calendar
  • 21
    Mar
    March 21, 2019
    Extra bolagsstämma 2019
    Add to calendar
  • 24
    Apr
    April 24, 2019
    Delårsrapport 1, 2019
    Add to calendar
  • 10
    May
    May 10, 2019
    Årsstämma 2019
    Add to calendar
  • 30
    Aug
    August 30, 2019
    Halvårsrapport, 2019
    Add to calendar
  • 11
    Nov
    November 11 - November 13, 2019
    Bio Europe in Hamburg
    Add to calendar
  • 15
    Nov
    November 15, 2019
    Delårsrapport 3, 2019
    Add to calendar
  • 18
    Nov
    November 18 - November 23, 2019
    Bio China in Shanghai
    Add to calendar
  • 11
    Feb
    February 11, 2020
    Bokslutskommuniké, 2019
    Add to calendar
  • 11
    Mar
    March 11, 2020
    Sedermeradagen Copenhagen
    Add to calendar
  • 23
    Mar
    March 23 - March 25, 2020
    Bio Europe 2020
    Add to calendar
  • 11
    May
    May 11, 2020
    Sedermeradagen Malmö
    Add to calendar
  • 13
    May
    May 13, 2020 10:00 CET
    Årstämma 2020
    Add to calendar
  • 08
    Jun
    June 8 - June 11, 2020
    Bio International Convention
    Add to calendar
  • 08
    Jun
    June 8, 2020 at around 09:00 CEST
    Småbolagsdagarna
    Add to calendar
  • 08
    Oct
    October 8, 2020
    Sedermeradagen Gothenburg
    Add to calendar
  • 26
    Oct
    October 26 - October 28, 2020
    Bio Europe 2020
    Add to calendar
  • 12
    Feb
    February 12, 2021
    Bokslutskommuniké, 2020
    Add to calendar
  • 22
    Mar
    March 22 - March 25, 2021
    Participation at Bio Europe
    Add to calendar
  • 05
    May
    May 5, 2021
    Interim report Q1 2021
    Add to calendar
  • 05
    May
    May 5, 2021
    Participation at The Kempen & Co Life Sciences Conference
    Add to calendar
  • 21
    May
    May 21, 2021
    Annual general Meeting 2021 / Årsstämma 2021
    Add to calendar
  • 25
    May
    May 25, 2021
    ABGSC Life Science Summit
    Add to calendar
  • 27
    Aug
    August 27, 2021
    Interim report Q2 2021
    Add to calendar
  • 25
    Oct
    October 25 - October 27, 2021
    Bio Europe
    Add to calendar
  • 09
    Nov
    November 9, 2021
    ACR Convergence 2021
    Add to calendar
  • 12
    Nov
    November 12, 2021
    Interim report Q3 2021
    Add to calendar
  • 07
    Dec
    December 7, 2021
    Sedermeradagen, Villa Copenhagen
    Add to calendar
  • 08
    Dec
    December 8, 2021
    ABGSC Investor Days
    Add to calendar
  • 10
    Jan
    January 10 - January 14, 2022
    JP Morgan in San Fransisco
    Add to calendar
  • 11
    Feb
    February 11, 2022
    Year-end report 2021
    Add to calendar
  • 28
    Mar
    March 28, 2022
    Extraordinary General Meeting March 2022
    Add to calendar
  • 28
    Mar
    March 28 - March 31, 2022
    Bio-Europe Spring
    Add to calendar
  • 28
    Mar
    March 28, 2022 10:00 CET
    Conference Call regarding Rights Issue 2022
    Add to calendar
  • 21
    Apr
    April 21, 2022
    Kempen Life Science Conference
    Add to calendar
  • 25
    Apr
    April 25, 2022
    Sedermeradagen – Hotel at Six, Stockholm
    Add to calendar
  • 29
    Apr
    April 29, 2022
    Annual Report 2021
    Add to calendar
  • 02
    May
    May 2, 2022
    Aktiespararna – Aktiedagen Stockholm
    Add to calendar
  • 18
    May
    May 18 - May 19, 2022
    ABGSC Life Science Summit
    Add to calendar
  • 20
    May
    May 20, 2022
    Annual General Meeting 2022
    Add to calendar
  • 30
    May
    May 30, 2022
    Interim Report Q1 2022
    Add to calendar
  • 01
    Jun
    June 1, 2022
    Økonomisk Ugebrev – Life Science Event Copenhagen
    Add to calendar
  • 08
    Jun
    June 8 - June 9, 2022
    BioStock Life Science Summit Spring
    Add to calendar
  • 13
    Jun
    June 13 - June 16, 2022
    BIO International Convention – San Diego, CA
    Add to calendar
  • 11
    Jul
    July 11, 2022
    Last day of trade of the SYNACT share at Spotlight Stock Market
    Add to calendar
  • 12
    Jul
    July 12, 2022
    First day of trade of the SYNACT share at Nasdaq Stockholm
    Add to calendar
  • 05
    Aug
    August 5, 2022
    Interim Report Q2 2022
    Add to calendar
  • 06
    Sep
    September 6 - September 7, 2022
    LSX Nordic Congress 2022 – Bella Sky Convention Center, Copenhagen
    Add to calendar
  • 28
    Sep
    September 28 - September 29, 2022
    NLSDays 2022
    Add to calendar
  • 04
    Nov
    November 4, 2022
    Interim Report Q3 2022
    Add to calendar
  • 14
    Nov
    November 14, 2022
    ACR Convergence 2022
    Add to calendar
  • 12
    Dec
    December 12, 2022 14:00 CET
    Telephone conference regarding the acquisition of TXP Pharma
    Add to calendar
  • 09
    Jan
    January 9 - January 12, 2023
    J.P. Morgan Annual Health Care Conference
    Add to calendar
  • 12
    Jan
    January 12, 2023
    Extraordinary General Meeting
    Add to calendar
  • 17
    Feb
    February 17, 2023
    Annual Results 2022
    Add to calendar
  • 05
    May
    May 5, 2023
    Interim Report Q1 2023
    Add to calendar
  • 25
    May
    May 25, 2023
    Annual General Meeting 2023
    Add to calendar
  • 04
    Jul
    July 4, 2023
    World Congress of Basic & Clinical Pharmacology 2023 – Thomas Jonassen presents AP1189 at a symposium on Resolution Therapy.
    Add to calendar
  • 04
    Aug
    August 4, 2023
    Interim Report Q2 2023
    Add to calendar
  • 03
    Nov
    November 3, 2023
    Interim Report Q3 2023
    Add to calendar
  • Investors
    • Listing Nasdaq 2022
    • Rights Issue 2022
    • Word from the CEO
    • Financial Reports
    • Investment highlights
    • Presentations
    • The Share
      • Share price development
      • Ownership Structure
      • Insiders
      • Share Capital Development
    • Analyst Coverage
    • Calendar
    • Press Releases
    • Prospectuses
Jeppe Øvlesen, MBA.
Jeppe Øvlesen, MBA.
Chief Executive Officer
+45 28 44 75 67
[email protected]
Patrik Renblad, MSc.
Patrik Renblad, MSc.
Chief Financial Officer
+4670 747 97 68
[email protected]

About Synact Pharma

SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation.

  • Privacy Policy
  • Cookies

Explore our Website

  • About us
  • Our Science
  • Pipeline
  • Investors
  • Governance
  • Media
  • Contact
  • LinkedIn

Subscribe